Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that it is the most widely used Certified Electronic Health Record Technology (CEHRT) by radiologists according to data compiled by the U.S. Department of Health and Human Services (HHS).
As of July 2013, more than 75 different CEHRT solutions were used for MU attestations by radiologists. Among the 10 most widely used CEHRT solutions, which account for 72 percent of MU radiology attestations, Merge is the leading solution.
“We were delighted to see the data from HHS recognize Merge RIS™ as the leader in radiology MU attestations. Combined with the recent recognition as ‘Best in Interoperability’ from Frost & Sullivan and IHS ranking Merge’s iConnect® Enterprise Archive as the #1 vendor-neutral archive, we are confident our solutions are providing radiologists and their networks with the tools they need to succeed in today’s market,” said Justin Dearborn, CEO of Merge. “Our ranking is a direct reflection of Merge’s commitment to the industry and our forward-thinking approach to imaging and data management.”
Merge began its commitment to the MU program in 2011 by transforming Merge RIS to be a complete, certified EHR as defined by the program measures. This process entailed expanding Merge RIS in such areas as clinical decision support and Clinical Quality Measures, while retaining core radiology clinical workflow. Customers began using Merge RIS to successfully report on MU that same year. Subsequently, Merge has worked with users to improve usability, teach others and exchange best practices so that the adoption of MU in radiology can continue efficiently.
“Meaningful Use attestation is a necessity in radiology, and leveraging Merge has helped make the process easy on our practice, ensuring that our radiologists qualify to receive their full incentives,” said Randy Hicks, MD, MBA, radiologist and owner of Radiology Medical Imaging (RMI). “With Merge, RMI now has a global view of our network, receives priority referrals from network physicians and has quick access to data to ensure higher quality care and accurate reimbursement.”
As the MU program moves into new measures and certification requirements in 2014, Merge continues to invest and develop solutions that will help radiology providers achieve success. In particular, MU Stage 2 contains new measures that provide guidelines for the ordering of imaging tests, and the incorporation of imaging reports and images into the EHR. In addition to Merge RIS, Merge has committed to certifying many of its imaging solutions in order to help customers achieve these measures. Furthermore, Merge’s new iConnect Network allows imaging centers to share imaging information with referring physicians and hospitals that are connected to Health Information Exchanges (HIEs) or EHR networks. This allows customers to not only support MU Stage 2 requirements, but also strengthen their relationships with referring physicians.
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare. Merge’s enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 25 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.
RMI began in 1985 as a private, outpatient-based imaging facility with a goal of offering patients an alternative to hospitals for radiology services. Today, RMI continues its commitment of providing state-of-the-art equipment in a patient-friendly atmosphere at its offices in Flint, Fenton, Grand Blanc and Davison. For more information, visit www.rmipc.net.
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.